
Renal cell carcinoma (RCC) prognosis muChina inosiyana zvakanyanya zvichienderana nezvinhu zvakati wandei, kusanganisira danho rekuongororwa, hunhu hwebundu, uye kuwana kurapwa. Ichi chinyorwa chinopa tarisiro yakazara yekunzwisisa kwazvino kwe China renal cell carcinoma prognosis, kuongorora zvinhu zvakakosha zvinokurudzira uye kufambira mberi kwekurapa.
Chiitiko uye kuwanda kweRCC muChina kuri kuwedzera, kuratidza maitiro epasirese. Nepo data chairo renyika yese richiri shoma, zvidzidzo zvemudunhu zvinoratidza kuwedzera kuri kuita, kunyanya munzvimbo dzemumaguta. Kuwanikwa kwekutanga kuona uye kuongorora zvirongwa zvinosiyana munyika yese, zvichikanganisa nhanho iyo RCC inowanzoonekwa. Kukurumidza kuongororwa kwakakosha pakuvandudza China renal cell carcinoma prognosis.
RCC staging, kazhinji uchishandisa iyo TNM system (Tumor, Node, Metastasis), ndiyo yakakosha gadziriso yekufungidzira. Matanho epamusoro anoratidza chirwere chepamusoro nemaonero asina kunaka. Histological subtypes yeRCC zvakare inopesvedzera kufungidzira, nesero rakajeka RCC iri iyo inonyanya kuzivikanwa mhando. Kunzwisisa hunhu hwebundu, kusanganisira kukura kwaro, nzvimbo, uye kuvapo kwemetastasis, kwakakosha pakufanotaura kwechokwadi. Iyo Shandong Baofa Cancer Research Institute (https://www.baofahospital.com/) inopa masevhisi epamusoro ekuongororwa.
Nhanho yeRCC panguva yekuongororwa ndiyo inonyanya kukosha prognostic factor. Early-stage RCC (nhanho I uye II) kazhinji inotakura fungidziro iri nani pane yepamusoro-nhanho RCC (nhanho III uye IV). Kuonekwa kwekukurumidza kuburikidza nekuongororwa nguva dzose uye kuongororwa nekukurumidza kwezviratidzo zvakakosha pakuvandudza mhedzisiro. Kuonekwa kwekutanga kwekutanga kunogona kukanganisa zvakanyanya China renal cell carcinoma prognosis.
Zvizhinji zvebundu-chaiyo maitiro anokanganisa kufungidzira. Izvi zvinosanganisira saizi yebundu, giredhi (chiyero chekuti masero egomarara anooneka sei pasi pemaikorosikopu), uye kuvapo kwenecrosis (kufa kwetishu). Uyezve, kuvapo kwe lymphovascular invasion (masero emukenza anopararira kune lymph iri pedyo kana mitsipa yeropa) inosanganiswa nemigumisiro yakaipa.
Nzira dzekurapa dzeRCC dzinosanganisira kuvhiyiwa (partial kana radical nephrectomy), kurapa kwakanangwa (senge tyrosine kinase inhibitors), immunotherapy (checkpoint inhibitors), uye kurapa kwemwaranzi. Kusarudzwa kwekurapa kunoenderana nezvinhu zvakasiyana zvinosanganisira danho regomarara, hutano hwemurwere hwese, uye kuwanikwa kwezvinhu. Kufambira mberi mune zvakanangwa uye immunotherapies zvakavandudza zvakanyanya China renal cell carcinoma prognosis mumakore achangopfuura. Aya mafambiro ari kuwedzera kuwanikwa mumaguta makuru.
Kuwanikwa kwehutano hwemhando yepamusoro, kusanganisira kuongororwa panguva, kurapwa kwakakodzera, uye kutarisirwa kwekutevera, kunokanganisa zvakanyanya China renal cell carcinoma prognosis. Zvemagariro ehupfumi zvinhu, senge nzvimbo, mazinga emari, uye kuvharirwa inishuwarenzi, zvinogona kukanganisa kuwanikwa kwekutarisirwa uye, nekudaro, mhedzisiro yekurapwa kweRCC. Kusiyana mukuwana rubatsiro kunobatsira mukusiyana kwekufungidzira munzvimbo dzakasiyana dzeChina. Tsvagiridzo inoratidza kuti kuvandudzwa kwekuwana nzvimbo dzehunyanzvi, dzakadai seShandong Baofa Cancer Research Institute, inotungamira kune zvirinani.
Mhando dzakasiyana dzekufungidzira dzinoshandiswa kufanotaura mukana wekupona uye kudzokazve kune varwere vane RCC. Aya mamodheru anosanganisira zvinhu zvakasiyana-siyana zvakurukurwa pamusoro apa uye anoshandiswa kutungamira sarudzo dzekurapa uye kuraira kwevarwere. Nepo aya mamodheru achipa ruzivo rwakakosha, zvakakosha kurangarira kuti anongori kufanotaura uye mhedzisiro yemunhu inogona kusiyana. Kushandiswa kwemhando idzi kwakakosha pakuzivisa kuongororwa kwe China renal cell carcinoma prognosis.
Disclaimer: Ruzivo urwu rwakaitirwa ruzivo rwese uye zvinangwa zveruzivo chete, uye haruunze zano rekurapa. Gara uchibvunzurudza nenyanzvi yezvehutano ine ruzivo rwezvehutano kana usati waita chero sarudzo dzine chekuita nehutano hwako kana kurapwa.
p>
parutivi>
body>